TYME - Tyme TechnologiesAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $2.16 | Open | $2.30 |
| Volume | 2.76M | Market Cap | 281.17M |
| Yield | Last Dividend |
| Tyme Technologies (NASDAQ:TYME) Upgraded... | 11/20/20 |
| Zacks Investment Research upgraded shares of Tyme Technologies (NASDAQ:TYME) from a hold rating to a buy rating in a research note published on Thursd... | |
| Tyme Technologies Inc (NASDAQ:TYME) CEO ... | 10/24/20 |
| Tyme Technologies Inc (NASDAQ:TYME) CEO Steve Hoffman sold 37,842 shares of Tyme Technologies stock in a transaction that occurred on Thursday, Octobe... | |
| Steve Hoffman Sells 37,842 Shares of Tym... | 10/23/20 |
| Tyme Technologies Inc (NASDAQ:TYME) CEO Steve Hoffman sold 37,842 shares of the firm???s stock in a transaction that occurred on Thursday, October 22n... | |
| Michael Demurjian Sells 20,000 Shares of... | 10/21/20 |
| Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the firm???s stock in a transaction that occurred on Fri... | |
| Tyme Technologies Inc (NASDAQ:TYME) Majo... | 10/21/20 |
| Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the company???s stock in a transaction on Friday, Octobe... | |
| Insider Selling: Tyme Technologies Inc (... | 10/20/20 |
| Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the firm???s stock in a transaction on Monday, October 1... | |
| Tyme Technologies to Present at Jefferie... | 10/13/20 |
| BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-ba... | |
| Tyme Technologies to Present at BioNJ???... | 09/14/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ:TYME), an emerging biotechnology company developing cancer metabolism-based thera... | |
| Tyme Technologies to Present at H.C. Wai... | 09/02/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| CRM, HPE among premarket gainers | 08/26/20 |
| Tyme Technologies (NASDAQ:TYME) +29%. as oncology research reveals potential new oral therapy TYME-19 in the fight against COVID-19. SCWorx (NASDAQ:WO... | |
| TYME???s Oncology Research Reveals Poten... | 08/26/20 |
| BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-ba... | |
| Tyme Technologies to Present at the 2020... | 08/21/20 |
| BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-ba... | |
| Insider Sells Tyme Technologies's Shares | 08/18/20 |
| Tyme Technologies Inc (NASDAQ:TYME) was trading 0.7% lower from the previous closing price. A Form 4 filing filed with the SEC on Tuesday, August 18 s... | |
| Why Tyme Technologies's Stock Is Trading... | 08/03/20 |
| Tyme Technologies (NASDAQ: TYME ) shares are trading higher on Monday after the company announced an orphan drug designation for its SM-88 as a potent... | |
| TYME Announces Orphan Drug Designation f... | 08/03/20 |
| BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-ba... | |
| Tyme Technologies to Present at Canaccor... | 07/21/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| TYME Provides Business Update and Announ... | 07/13/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| Tyme Technologies Announces Virtual 2020... | 07/10/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| Edited Transcript of TYME.OQ earnings co... | 06/28/20 |
| Q4 2020 Tyme Technologies Inc Earnings Call | |
| TYME-18 Demonstrates Anti-Cancer Effect ... | 06/23/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| TYME Presents New Preclinical Data Suppo... | 06/22/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| Tyme Technologies to Present at BIO Digi... | 05/27/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| TYME Announces Fourth Quarter and Fiscal... | 05/20/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| Tyme Technologies to Present at Jefferie... | 05/19/20 |
| Tyme Technologies, Inc. (NASDAQ:TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs???), announced that leade... | |
| Health Economic Research Study Presented... | 05/18/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism based ther... | |
| TYME Announces Abstracts Selected for Pr... | 05/15/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| Tyme Technologies to Webcast Conference ... | 05/12/20 |
| NEW YORK--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ:TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBT... | |
| Tyme Technologies to Present at the 2020... | 04/06/20 |
| NEW YORK--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMB... | |
| Circling Back On Tyme Technologies | 01/20/20 |
| Today, we circle back on lottery ticket Tyme Technologies. Over the past month, the company has signed a collaboration deal and began dosing in a key ... | |
| Tyme Technologies: An Investment Update ... | 01/18/20 |
| Today, we circle back on Tyme Technologies (TYME). The stock has nearly doubled since we dubbed it a worthy '$1 lottery ticket' back in early August. ... | |
| Date | 2020-11-12 (BMO) | Est. (EPS/Rev.) | ($0.06)/ 0 |
| Actual (EPS/Rev.) | $-0.05/ | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 66.00 % | Follow |
| R R Investments | Roland Van Rij | 38.00 % | Follow |
| JBloombiz1 | J Bloom | 0.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
